Association of epithelial mesenchymal transition (EMT) markers and outcome measures in advanced non-small cell lung cancer (NSCLC) patients treated with erlotinib
| Autor: | Eduardo Braun, Thomas A. Hensing, P. Bonomi, N. B. Shah, H. Harasty, Mary J. Fidler, Sanjib Basu, Mark Pool, John S. Coon, Kelly Kaiser Walters |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Oncology
Cancer Research medicine.medical_specialty biology business.industry Outcome measures non-small cell lung cancer (NSCLC) Vimentin macromolecular substances medicine.disease respiratory tract diseases Internal medicine medicine biology.protein Erlotinib Epithelial–mesenchymal transition business neoplasms medicine.drug |
| Zdroj: | Journal of Clinical Oncology. 28:7550-7550 |
| ISSN: | 1527-7755 0732-183X |
| Popis: | 7550 Background: Our objective was to explore potential relationships to clinical outcomes of advanced NSCLC erlotinib treated patients (pts) with EMT markers e-cadherin (e-cad) and vimentin (vim).... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|